MULTICOHORT STUDY TO CUSTOMIZE IBRUTINIB TREATMENT REGIMENS FOR PATIENTS WITH PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA
- Registry ID
- 54179060CLL2032
- Source registry
- HEALTH_CANADA
- Status
- Ongoing
- Study type
- INTERVENTIONAL
- Sponsor
- JANSSEN INC
- Start date
- 2024-05-22
- Last update
- 2023-08-21
Conditions
- CHRONIC LYMPHOCYTIC LEUKEMIA
Related clinical trials
- A PHASE III, RANDOMISED, OPEN-LABEL, MULTICENTRE, STUDY OF SUROVATAMIG AS CONSOLIDATION THERAPY VERSUS OBSERVATION AFTER FIRST-LINE INDUCTION THERAPY IN PARTICIPANTS WITH CHRONIC LYMPHOCYTIC LEUKAEMIA OR SMALL LYMPHOCYTIC LYMPHOMA WITH UNMUTATED IGHV (SOUNDTRACK-C1)
- AN OPEN-LABEL, PHASE 1/2 STUDY OF JCAR017 IN SUBJECTS WITH RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA OR SMALL LYMPHOCYTIC LYMPHOMA
- A PHASE 2, OPEN-LABEL, RANDOMIZED STUDY EVALUATING THE EFFICACY AND SAFETY
OF 3 DOSES OF PIRTOBRUTINIB IN PARTICIPANTS WITH RELAPSED OR REFRACTORY CHRONIC
LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA WHO PREVIOUSLY
RECEIVED TREATMENT WITH A COVALENT BRUTON TYROSINE KINASE INHIBITOR
- A PHASE 3, RANDOMIZED STUDY TO COMPARE NEMTABRUTINIB VERSUS COMPARATOR (INVESTIGATOR'S CHOICE OF IBRUTINIB OR ACALABRUTINIB) IN PARTICIPANTS WITH UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA (BELLWAVE-011)
- A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY OF SONROTOCLAX (BGB-11417) PLUS
ZANUBRUTINIB (BGB-3111) COMPARED WITH VENETOCLAX PLUS OBINUTUZUMAB IN
PATIENTS WITH PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA
- A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY TO COMPARE THE EFFICACY AND SAFETY OF NEMTABRUTINIB (MK-1026) PLUS VENETOCLAX VERSUS VENETOCLAX PLUS RITUXIMAB IN PARTICIPANTS WITH RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA FOLLOWING AT LEAST 1 PRIOR THERAPY (BELLWAVE-010)
View on source registry